Ellen W. Baxter

1.1k total citations
20 papers, 600 citations indexed

About

Ellen W. Baxter is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Ellen W. Baxter has authored 20 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 10 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Ellen W. Baxter's work include Chemical Synthesis and Analysis (5 papers), Alzheimer's disease research and treatments (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ellen W. Baxter is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Alzheimer's disease research and treatments (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ellen W. Baxter collaborates with scholars based in United States. Ellen W. Baxter's co-authors include Allen B. Reitz, Jaimie K. Rueter, Richard J. Sundberg, Patrick S. Mariano, David Labaree, Kelly A. Conway, Kevin M. Felsenstein, Gregory C. Leo, Herman L. Ammon and William J. Pitts and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Ellen W. Baxter

20 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen W. Baxter United States 15 444 358 52 51 50 20 600
Dušan Berkeš Slovakia 17 327 0.7× 384 1.1× 35 0.7× 37 0.7× 41 0.8× 56 684
Annalina Lapucci Italy 16 446 1.0× 307 0.9× 135 2.6× 46 0.9× 29 0.6× 53 749
Jason Elliott United Kingdom 17 640 1.4× 311 0.9× 63 1.2× 28 0.5× 70 1.4× 38 865
Pauline J. Sanfilippo United States 14 518 1.2× 350 1.0× 61 1.2× 20 0.4× 69 1.4× 21 1.1k
Brian Heasley United States 12 294 0.7× 351 1.0× 50 1.0× 23 0.5× 32 0.6× 14 637
Bernard Hulin United States 15 339 0.8× 307 0.9× 101 1.9× 48 0.9× 46 0.9× 23 645
Karl R. Gibson United Kingdom 15 460 1.0× 255 0.7× 96 1.8× 36 0.7× 29 0.6× 27 796
Panagiota Moutevelis‐Minakakis Greece 14 296 0.7× 345 1.0× 49 0.9× 17 0.3× 46 0.9× 28 554
Shane A. Eisenbeis United States 11 230 0.5× 193 0.5× 27 0.5× 53 1.0× 28 0.6× 18 464
Brian T. O’Neill United States 16 547 1.2× 223 0.6× 96 1.8× 94 1.8× 58 1.2× 28 796

Countries citing papers authored by Ellen W. Baxter

Since Specialization
Citations

This map shows the geographic impact of Ellen W. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen W. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen W. Baxter more than expected).

Fields of papers citing papers by Ellen W. Baxter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen W. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen W. Baxter. The network helps show where Ellen W. Baxter may publish in the future.

Co-authorship network of co-authors of Ellen W. Baxter

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen W. Baxter. A scholar is included among the top collaborators of Ellen W. Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen W. Baxter. Ellen W. Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yifang, Chih Y. Ho, Charles H. Reynolds, et al.. (2010). Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads. Bioorganic & Medicinal Chemistry Letters. 20(10). 3158–3160. 21 indexed citations
2.
Chiu, George, Peter J. Connolly, Steven A. Middleton, et al.. (2008). α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms. Expert Opinion on Therapeutic Patents. 18(12). 1351–1360. 5 indexed citations
3.
Tounge, Brett A., Ramkumar Rajamani, Ellen W. Baxter, Allen B. Reitz, & Charles H. Reynolds. (2005). Linear interaction energy models for β-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms. Journal of Molecular Graphics and Modelling. 24(6). 475–484. 19 indexed citations
4.
Conway, Kelly A., Ellen W. Baxter, Kevin M. Felsenstein, & Allen B. Reitz. (2004). Emerging β-Amyloid Therapies for the Treatment of Alzheimer's Disease. 1(1). 361–384. 5 indexed citations
5.
Conway, Kelly A., Ellen W. Baxter, Kevin M. Felsenstein, & Allen B. Reitz. (2003). Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease. Current Pharmaceutical Design. 9(6). 427–447. 34 indexed citations
6.
Baxter, Ellen W. & Allen B. Reitz. (2003). Reductive Aminations of Carbonyl Compounds with Borohydride and Borane Reducing Agents.. ChemInform. 34(19). 38 indexed citations
7.
Baxter, Ellen W., et al.. (2001). Piperazinyl benzamidines: Synthesis and affinity for the delta opioid receptor. Bioorganic & Medicinal Chemistry Letters. 11(13). 1741–1743. 1 indexed citations
8.
Reitz, Allen B., Ellen W. Baxter, Ellen E. Codd, et al.. (1998). Orally Active Benzamide Antipsychotic Agents with Affinity for Dopamine D2, Serotonin 5-HT1A, and Adrenergic α1Receptors. Journal of Medicinal Chemistry. 41(12). 1997–2009. 27 indexed citations
9.
Rueter, Jaimie K., et al.. (1998). Arylsulfonate esters in solid phase organic synthesis. I. Cleavage with amines, thiolate, and imidazole. Tetrahedron Letters. 39(9). 975–978. 48 indexed citations
10.
Baxter, Ellen W., et al.. (1998). Arylsulfonate esters in solid phase organic synthesis. II. Compatibility with commonly-used reaction conditions. Tetrahedron Letters. 39(9). 979–982. 36 indexed citations
11.
Reitz, Allen B., et al.. (1997). The synthesis and evaluation of the major metabolites of mazapertine. Bioorganic & Medicinal Chemistry Letters. 7(14). 1927–1930. 11 indexed citations
12.
Baxter, Ellen W. & Allen B. Reitz. (1997). Hindered rotation congeners of mazapertine: High affinity ligands for the 5-HT1A receptor. Bioorganic & Medicinal Chemistry Letters. 7(7). 763–768. 8 indexed citations
13.
Scott, Malcolm K., Ellen W. Baxter, Robert E. Boyd, et al.. (1995). Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents. Journal of Medicinal Chemistry. 38(21). 4198–4210. 18 indexed citations
14.
Baxter, Ellen W. & Allen B. Reitz. (1994). Expeditious Synthesis of Aza sugars by the Double Reductive Amination of Dicarbonyl Sugars. The Journal of Organic Chemistry. 59(11). 3175–3185. 147 indexed citations
15.
Baxter, Ellen W. & Allen B. Reitz. (1992). Concise synthesis of 1-deoxymannojirimycin. Bioorganic & Medicinal Chemistry Letters. 2(11). 1419–1422. 20 indexed citations
16.
Baxter, Ellen W., David Labaree, Herman L. Ammon, & Patrick S. Mariano. (1990). Formal total synthesis of deserpidine demonstrating a versatile amino-Claisen rearrangement/Wenkert cyclization strategy for the preparation of functionalized yohimbane ring systems. Journal of the American Chemical Society. 112(21). 7682–7692. 33 indexed citations
17.
Reitz, Allen B. & Ellen W. Baxter. (1990). Pyrrolidine and piperidine aminosugars from dicarbonyl sugars in one step. Concise synthesis of 1-deoxynojirimycin. Tetrahedron Letters. 31(47). 6777–6780. 63 indexed citations
18.
19.
20.
Sundberg, Richard J. & Ellen W. Baxter. (1986). Photochemistry of quinone diazides. Intramolecular oxygen transfer and carbenoid addition during photolysis of N-allylsulfonamido quinone diazides. Tetrahedron Letters. 27(24). 2687–2690. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dušan Berkeš Breakdown of academic impact, for papers by Annalina Lapucci Breakdown of academic impact, for papers by Jason Elliott Breakdown of academic impact, for papers by Pauline J. Sanfilippo Breakdown of academic impact, for papers by Brian Heasley Breakdown of academic impact, for papers by Bernard Hulin Breakdown of academic impact, for papers by Karl R. Gibson Breakdown of academic impact, for papers by Panagiota Moutevelis‐Minakakis Breakdown of academic impact, for papers by Shane A. Eisenbeis Breakdown of academic impact, for papers by Brian T. O’Neill
Rankless by CCL
2026